IVF Hartmann Holding AG
SIX:VBSN

Watchlist Manager
IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG
SIX:VBSN
Watchlist
Price: 137.5 CHF -1.08% Market Closed
Market Cap: CHf330m

IVF Hartmann Holding AG
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

IVF Hartmann Holding AG
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
IVF Hartmann Holding AG
SIX:VBSN
Total Equity
CHf155.4m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
5%
Alcon AG
SIX:ALC
Total Equity
$22B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Total Equity
CHf100.5m
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Total Equity
CHf275.9m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Total Equity
CHf807.2m
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
12%
No Stocks Found

IVF Hartmann Holding AG
Glance View

Market Cap
330m CHF
Industry
Health Care

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.

VBSN Intrinsic Value
154.12 CHF
Undervaluation 11%
Intrinsic Value
Price CHf137.5

See Also

What is IVF Hartmann Holding AG's Total Equity?
Total Equity
155.4m CHF

Based on the financial report for Dec 31, 2025, IVF Hartmann Holding AG's Total Equity amounts to 155.4m CHF.

What is IVF Hartmann Holding AG's Total Equity growth rate?
Total Equity CAGR 10Y
5%

Over the last year, the Total Equity growth was 2%. The average annual Total Equity growth rates for IVF Hartmann Holding AG have been 3% over the past three years , 2% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett